Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:2187

Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market

Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $3,500.00
Meta Description Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval
Publisher GBI Research
Date of Report Jan 7, 2011
Quick Overview
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market

Summary

GBI Research, the leading business intelligence provider, has released its latest report, “Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market” which provides key data, information and analysis of the major trends and issues affecting the clinical trial market in Brazil. The report provides a comprehensive insight of the reasons for outsourcing clinical trials to Brazil and the key services provided by the Clinical Research Organizations (CROs) of Brazil. The report provides a detailed analysis of the Brazilian market in terms of its size, and major service offerings of the CROs in Brazil. The report also discusses the factors that are driving the clinical trial market in Brazil. The report delves into the key documents required by the investigator and the sponsor before, during and after the conduct of clinical trials. The report also provides key alliances between the CROs of other countries and the local CROs of Brazil. Furthermore, the report looks into the major challenges that can restrict the growth of the clinical trials market in Brazil.

Scope

The report analyses the clinical trial market in Brazil, along with the major forces driving the current market and the potential challenges that could restrain the growth. The scope of the report includes -
- The need for outsourcing clinical trials to Brazil.
- Trends in clinical trial registration in Brazil and a comparative analysis of clinical trial registration in Brazil, Russia, India and China (BRIC) and six major Latin American countries.
- Analysis of the key drivers that are fueling the growth of the clinical trial market in Brazil.
- Analysis of the key infrastructural facilities, clinical research professionals and principal investigators in Brazil.
- Analysis of key government regulations in Brazil affecting the clinical trial market.
- Study of 13 major CROs operating in Brazil with SWOT analysis of large multinational CROs.

Reasons to buy

The report will enhance your decision making capability in a rapid and time-sensitive manner. It will allow you to -
- Compare the key capabilities of major clinical trial service providers with your requirements and optimize your R&D costs.
- Develop market entry and market expansion strategies by identifying the key drivers and challenges in the Brazilian clinical trials market.
- Develop effective strategies to maximize the advantages in Brazil through understanding of the regulatory environment.
- Understand the regulatory structure in Brazil and key documents required to register clinical trials in Brazil.
Table of Contents
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7
2 Emerging Market for Clinical Trials in Brazil – Introduction 9
2.1 GBI Research Report Guidance 10
3 Emerging Market for Clinical Trials, Brazil - Market Overview 11
3.1 The Clinical Research Process- Overview 11
3.1.1 Drug Discovery 11
3.1.2 Pre-clinical Study/Development 12
3.1.3 Clinical Trials 12
3.2 Clinical TrialDesign and Types 13
3.2.1 Types of Design 13
3.3 Role of CROs 18
3.4 Sponsors of Clinical Trials 20
3.5 The Need for Outsourcing Clinical Trials 21
3.5.1 High Risks and Costs Associated With Drug Development 21
3.5.2 Escalating Costs of Clinical Trials 22
3.5.3 Global Increase in the Number of Clinical Trials Conducted 23
3.5.4 Restructuring the R&D 24
3.5.5 Increased Screening Rates during R&D 25
3.5.6 Expiring Patents Pressurize Pharmaceutical Companies to Reduce Costs 25
4 Emerging Market for Clinical Trials, Brazil - Clinical Trial Trends 26
4.1 Analysis of Clinical Trials Registered in Brazil 26
4.1.1 Clinical Trials Registered in 2010 26
4.1.2 Registration of Phase I Clinical Trials 27
4.1.3 Registration of Phase II Clinical Trials 28
4.1.4 Registration of Phase III Clinical Trials 29
4.1.5 Registration of Phase IV Clinical Trials 30
4.2 Comparative Analysis of Registered Clinical Trials in Brazil, Russia, Brazil and China (BRIC) Countries 31
4.3 Comparative Analysis of Registered Clinical Trials in Six Major Countries of Latin America 32
4.4 Comparative Analysis of Population Statistics 33
4.4.1 Distribution of Population among Six Major Countries of Latin America 33
4.4.2 Population Forecast of Brazil 34
4.5 Comparative Analysis of Industry-sponsored Clinical Trials Registered in US Trials Registry 35
4.5.1 Industry-sponsored Clinical Trials Registered in BRIC Countries 35
4.5.2 Industry-sponsored Clinical Trials Registered in Six Major Countries of Latin America 36
4.6 Analysis of Clinical Trials Registered by MNCs in Brazil 37
4.7 Comparative Analysis of Sites for Industry-sponsored Clinical Trials Registered in Six Major Countries of Latin America 38
4.7.1 Number of Registered Sites for Industry-sponsored Clinical Trials 38
4.7.2 Number of Multinational Sites Registered for Industry-sponsored Trials (Phase II / III) 39
4.7.3 Number of Local Sites Registered for Industry-sponsored Trials (Phase II/III) 42
4.8 Number of Recruiting Sites by Multinational Companies (MNCs) in Brazil 45
4.9 Number of Recruiting Sites for Major Therapeutic Areas in Brazil 46
5 Emerging Market for Clinical Trials, Brazil - Market Characterization 48
5.1 Increase in Growth of Global CRO Market will Foster the Growth of the Clinical Trial Market in Brazil 48
5.1.1 Increase in Multinational Sites to Conduct Clinical Trials will Drive the Clinical Trial Market in Brazil 49
5.1.2 Access to a Large Patient Pool 50
5.1.3 Patient Availability for Major Diseases 51
5.1.4 Subject Recruitment, Retention and Speed of Trials 55
5.1.5 Cost Advantage in Brazil 60
5.1.6 Favorable Clinical Infrastructure Improve the Clinical Trial Environment 60
5.1.7 Qualified and Experienced Talent Pool 62
5.1.8 Good Quality of Clinical Trial Data 64
5.2 Market Restraints 64
5.2.1 Issues Related to Intellectual Property and New Medicine Approval 64
5.2.2 Cultural and Socioeconomic Factors Could Cause Problems in Conducting Clinical Research 64
5.3 Clinical Trial Market Size in Brazil 65
6 Emerging Market for Clinical Trials, Brazil - Regulatory Landscape 66
6.1 Introduction 66
6.2 Regulatory Provisions in Brazil Related to Clinical Trials 66
6.3 Major Regulatory Authorities/Institutions in Brazil 67
6.3.1 Ministry of Health (MOH) 67
6.3.2 Agência Nacional de Vigilância Sanitária (ANVISA) 67
6.3.3 Ethics Committees 68
6.4 Key Documents For Conducting Clinical Trials in Brazil 68
6.4.1 Additional Country Specific Documents to be Submitted in Brazil 70
6.5 Clinical Trial Regulation in Brazil 71
6.5.1 Approval Process for Clinical Trials in Brazil 71
6.5.2 Documents Required With the Investigator and Sponsor of Clinical Trials 72
6.6 Recent Regulatory Changes in Clinical Trials 75
6.6.1 Parallel Approval Process by CONEP and ANVISA 75
7 Emerging Market for Clinical Trials, Brazil - CRO Landscape 76
7.1 CRO Profiles 76
7.1.1 Quintiles 76
7.1.2 Covance 78
7.1.3 Kendle 80
7.1.4 PPD 82
7.1.5 PRA International 84
7.1.6 Chiltern 86
7.1.7 ICON plc. 88
7.1.8 Omnicare 90
7.1.9 INC Research 92
7.1.10 PAREXEL 94
7.1.11 Intrials 96
7.1.12 Eurotrials 97
7.1.13 PGS Medical/Statistics 98
7.2 Major Deals in the Brazilian CRO Market 99
7.2.1 Deal Summary 99
8 Emerging Market for Clinical Trials – Brazil - Appendix 100
8.1 Market Definitions 100
8.2 Abbreviations 100
8.3 Research Methodology 101
8.3.1 Coverage 101
8.3.2 Secondary Research 101
8.3.3 Primary Research 101
8.3.4 Expert Panel Validation 102
8.4 Contact Us 102
8.5 Disclaimer 102
8.6 Sources 103




...